Azacytidine: first therapeutic opportunity for myelodysplastic syndromes. Hematol Meeting Rep [Internet]. 2009 Jun. 8 [cited 2025 Aug. 8];2(7). Available from: https://journals.pagepress.org/hmr/article/view/415